Publication of ARRIVE Trial Linked to Increase in 39-Week Induction
FRIDAY, Aug. 11, 2023 (HealthDay News) — An increase in 39-week induction rates and a decrease in cesarean delivery (CD) rates were seen following publication of A Randomized Trial of Induction vs Expectant Management (ARRIVE) in August 2018, accordi…
Learn MoreCo-Occurrence of Psoriasis and Rheumatic Diseases Common
FRIDAY, Aug. 11, 2023 (HealthDay News) — Psoriasis is associated with rheumatic diseases, according to a study published online Aug. 5 in the Journal of the American Academy of Dermatology.Mimi Chung, from the University of California in San Francisc…
Learn MoreStudy Looks at Impact of Low Vitamin K on Lung Function
FRIDAY, Aug. 11, 2023 (HealthDay News) — Low vitamin K status is associated with lower ventilatory capacity and with increased odds of chronic obstructive pulmonary disease (COPD), wheezing, and asthma, according to a study published online Aug. 9 in…
Learn MoreRecommendations Developed for Acetaminophen Poisoning
THURSDAY, Aug. 10, 2023 (HealthDay News) — In a consensus statement published online Aug. 8 in JAMA Network Open, recommendations are presented for the management of patients with acetaminophen poisoning.Richard C. Dart, M.D., Ph.D., from the Univers…
Learn MoreMisdiagnosis Common for Suspected Myelodysplastic Neoplasms
FRIDAY, Aug. 11, 2023 (HealthDay News) — For patients with suspected myelodysplastic neoplasms (MDS), diagnoses are often discordant for local clinical sites and central, adjudicated review, according to a study published online Aug. 8 in Blood Advan…
Learn MoreModel Predicts New Psoriatic Arthritis in People With Psoriasis
FRIDAY, Aug. 11, 2023 (HealthDay News) — The development of psoriatic arthritis (PsA) can be predicted with reasonable accuracy for psoriasis patients, according to a study published online Aug. 9 in Arthritis & Rheumatology.Lihi Eder, M.D., Ph.D., f…
Learn MoreModerna COVID-19 Vaccine Tied to Lower Adverse Event Risk in Older Adults
FRIDAY, Aug. 11, 2023 (HealthDay News) — The mRNA-1273 (Moderna) vaccine against COVID-19 is associated with a slightly lower risk for several adverse events in older adults compared with BNT162b2 (Pfizer), according to a study published online Aug. …
Learn More